Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01583296 · ClinicalTrials.gov registry record · NA

LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT01583296: Completed NA study, sponsored by Albert Einstein College of Medicine.

NCT01583296 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01583296, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

The research plan involves two aims: 1) Cultural adaptation of the Panic-Asthma Treatment and 2) a randomized, placebo-controlled pilot study. Participants will be primarily recruited from two major, inner-city hospitals in the Bronx, NY. Diagnosis of Panic Disorder (PD) will be based on the Structured Clinical Interview for DSM-IV. Diagnosis of asthma will be based on national guidelines. The first year of the project will be devoted to approximately 5 focus groups with Latino (primarily Puerto Rican) participants, pilot treatment and participant feedback. The protocol will be adapted based on key cultural issues that are systematically observed during Phase 1. During Years 2-3, 40 participants with PD and asthma will be randomized into two treatment arms: Panic-Asthma Treatment and an active placebo condition involving music therapy and paced breathing at resting respiration rates. Each treatment will involve 8 weekly sessions. An interviewer, who will be blind to treatment condition, will conduct assessments at pre-treatment, mid-treatment, post-treatment, and 3-month follow-up. The primary hypotheses are that participants in the Panic-Asthma treatment group will have greater decreases than subjects in the placebo condition on the PD severity scale and albuterol use (i.e., rescue asthma medication) from pre-test to post-test and across 3-month follow-up.

Primary Outcome

The Panic Disorder Severity Scale (PDSS) is a clinician-administered questionnaire used to assess the severity of panic attacks. The PDSS consists of seven items with each ranging in severity from 0 (none) - 4 (extreme); so total score ranges from 0 to 28.

Interventions

  • BEHAVIORAL Music Relaxation Therapy (MRT)
  • BEHAVIORAL CBT and HRVB

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2010-07
Est. Completion 2013-12
Phase NA
Albert Einstein College of Medicine

175 total trials

What the finished NCT01583296 record still lists

NCT01583296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Music Relaxation Therapy (MRT) is the first listed.

NCT01583296 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01583296 about?

NCT01583296 is a clinical study titled "LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction". The research plan involves two aims: 1) Cultural adaptation of the Panic-Asthma Treatment and 2) a randomized, placebo-controlled pilot study. Participants will be primarily recruited from two major, inner-city hospitals in the Bronx, NY. Diagnosis of Panic Disorder (PD) will be based on the Structu...

What is the current status of trial NCT01583296?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2010-07. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01583296?

The interventions under investigation include: Music Relaxation Therapy (MRT) (BEHAVIORAL), CBT and HRVB (BEHAVIORAL).

Who is sponsoring clinical trial NCT01583296?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01583296's enrollment target sits among peer trials

53 1271st of 2000 higher than 729 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01583296, the US trial registry maintained by the National Library of Medicine. NCT01583296 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.